All Companies

ABTCongressional Stock Trades

Abbott Laboratories

Pharmaceutical Preparations

Congressional stock trades in Abbott Laboratories (ABT) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

Total Trades

49

Politicians Trading

19

Last Traded

Jul 30, 2026

Trading History

PoliticianNotifiedTradedTypeAmountChange
Richard McCormickRJul 9, 2026Jun 12, 2026Buy$1,001 - $15,000+16.36%
Richard McCormickRJul 9, 2026Jun 12, 2026Buy$1,001 - $15,000+16.36%
Ro KhannaDJul 6, 2026Jun 30, 2026Buy$1,001 - $15,000+13.08%
Ro KhannaDJul 6, 2026Jun 2, 2026Buy$1,001 - $15,000+17.98%
Gilbert Ray Cisneros, Jr.DJul 2, 2026Jun 16, 2026Buy$1,001 - $15,000+13.23%
Ro KhannaDJun 9, 2026May 15, 2026Buy$15,001 - $50,000+21.48%
Ro KhannaDJun 9, 2026May 1, 2026Buy$15,001 - $50,000+14.70%
Thomas H. Kean, Jr.RFeb 19, 2026Jan 29, 2026Buy$1,001 - $15,000-3.28%
Gilbert Ray Cisneros, Jr.DDec 15, 2025Nov 18, 2025Buy$1,001 - $15,000-21.07%
Richard McCormickRDec 9, 2025Nov 5, 2025Buy$1,001 - $15,000-17.61%
Rick LarsenDOct 16, 2025Oct 6, 2025Buy$1,001 - $15,000-23.28%
Thomas H. Kean, Jr.RAug 20, 2025Jul 21, 2025Buy$1,001 - $15,000-17.53%
Lisa C. McClainRAug 13, 2025Jun 24, 2025Buy$1,001 - $15,000-25.69%
Bruce WestermanRApr 16, 2025Mar 3, 2025Buy$1,001 - $15,000-26.82%
Byron DonaldsRApr 14, 2025Mar 20, 2025Buy$1,001 - $15,000-19.06%
Byron DonaldsRApr 14, 2025Mar 20, 2025Buy$1,001 - $15,000-19.06%
Josh GottheimerDMar 6, 2025Feb 13, 2025Buy$1,001 - $15,000-22.14%
Josh GottheimerDFeb 10, 2025Jan 29, 2025Buy$1,001 - $15,000-19.75%
Josh GottheimerDFeb 10, 2025Jan 28, 2025Buy$1,001 - $15,000-19.45%

Price History

About Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.